Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Appl Microbiol ; 86(1): 135-44, 1999 Jan.
Article in English | MEDLINE | ID: mdl-10030017

ABSTRACT

Human and bovine lactoferrins (Lfs) and bovine lactoferrin hydrolysate (LH) were assessed in vitro and in vivo for their antibacterial effects on Staphylococcus aureus. Lactoferrins showed weak in vitro antibacterial activity while Fe-saturated Lfs and LH showed no activity. Lactoferrin-treated mice (1 mg, i.v.) when injected i.v. with 10(6) staphylococci, showed 30-50% reduction in kidney infections, and viable bacterial counts in the kidneys decreased 5-12-fold. The inhibitory effect was dose-dependent up to 1 mg Lf. Lactoferrins were effective when given 1 day prior to the bacterial challenge, after which there was no significant effect even at doses up to 5 mg. Apo- and Fe-saturated forms of human and bovine Lfs were all equally effective, while LH was not protective. Human and bovine Lfs with different degrees of iron saturation (9-97%) were found to be equipotent. Feeding mice with 2% bLf in drinking water also reduced the kidney infections by 40-60%, and viable bacterial counts, 5-12-fold. The results suggest a potential for the use of Lfs as natural antibacterial proteins for preventing bacterial infections.


Subject(s)
Kidney Diseases/drug therapy , Lactoferrin/pharmacology , Staphylococcal Infections/drug therapy , Staphylococcus aureus/drug effects , Animals , Cattle , Colony Count, Microbial , Humans , Iron/pharmacology , Kidney/microbiology , Kidney Diseases/microbiology , Kidney Diseases/prevention & control , Lactoferrin/administration & dosage , Mice , Microbial Sensitivity Tests , Staphylococcal Infections/microbiology , Staphylococcal Infections/prevention & control
2.
Cancer Detect Prev ; 19(3): 292-8, 1995.
Article in English | MEDLINE | ID: mdl-7750119

ABSTRACT

Tumor promoter-stimulated polymorphonuclear leukocytes (PMNs) produce excessive H2O2, which contributes to inflammation and carcinogenesis. A new model to study 12-O-tetradecanoylphorbol-13-acetate (TPA)-mediated H2O2 formation and its suppression by chemopreventive agents was developed using human promyelocytic leukemic HL-60 cells and validated by comparing results with those obtained using human PMNs. Equal H2O2 (20 to 25 nmol/ml) was generated by TPA-activated PMNs (2.5 x 10(5)/ml) and TPA-treated dimethylsulfoxide (DMSO)-differentiated HL-60 cells (5 x 10(5)/ml). The chemopreventive agent-mediated inhibition of TPA-induced H2O2 formation was also comparable in both cell types. These results suggest that HL-60 cells can become a useful in vitro system to screen rapidly for chemopreventive agents and to study their properties.


Subject(s)
Antineoplastic Agents/pharmacology , Hydrogen Peroxide/metabolism , Leukemia, Promyelocytic, Acute/metabolism , Adult , Dimethyl Sulfoxide , Female , Humans , Leukemia, Promyelocytic, Acute/drug therapy , Leukocytes/drug effects , Leukocytes/metabolism , Tetradecanoylphorbol Acetate , Tumor Cells, Cultured
3.
Cancer Res ; 53(19): 4528-33, 1993 Oct 01.
Article in English | MEDLINE | ID: mdl-7691399

ABSTRACT

12-O-Tetradecanoylphorbol-13-acetate (TPA)-mediated oxidative stress in HeLa cells and its inhibition were studied by fluorometric measurement of H2O2 and by 3H-postlabeling of the oxidized bases 8-hydroxyl-2'-deoxyguanosine (8-OHdG) and 5-hydroxymethyl-2'-deoxyuridine (HMdU). TPA treatment (10 fmol/cell) caused approximately 7-fold increase in H2O2 levels (0.1 nmol TPA/ml), and 5-10-fold increase in 8-OHdG and HMdU (10 nmol TPA/ml). Naturally occurring compounds [caffeic acid phenethyl ester (CAPE), (-).epigallocatechin gallate (EGCG), penta-O-galloyl-beta-D-glucose (PGG) and sarcophytol A (Sarp A)] and the anticancer drug tamoxifen (TAM) were tested as potential chemopreventive agents. These agents dose-dependently inhibited TPA-induced H2O2, 8-OHdG and HMdU. The doses required for a 50% decrease in H2O2 were approximately 2.5 microM for TAM; 5 microM for CAPE, EGCG and PGG; and 75 microM for Sarp A. TAM and PGG (10 microM), EGCG (25 microM), and CAPE (50 microM) abolished TPA-mediated H2O2 production, even below the normal cellular levels. TAM (2.5-20 microM) decreased TPA-mediated HMdU and 8-OHdG formation 2-29 times. Maximum inhibition occurred at 20 microM TAM, which caused an approximately 95% decline in HMdU and 8-OHdG. CAPE was effective at 0.5-50 microM. CAPE (25 microM) decreased 8-OHdG 95%, and HMdU 58%, while Sarp A (250 microM) reduced 8-OHdG by 93% and HMdU by 78%. EGCG (1-25 microM) and PGG (1-10 microM) inhibited of 8-OHdG and HMdU dose-dependently. However, higher doses (50 and 100 microM) decreased the efficacy of that inhibition. Of those agents tested, TAM appears to be the most and Sarp A the least effective. Our results point to these 5 compounds as being potential chemopreventive agents, which at very low doses decrease the tumor promoter-mediated oxidative processes.


Subject(s)
Anticarcinogenic Agents/pharmacology , Antineoplastic Agents/pharmacology , DNA, Neoplasm/metabolism , Hydrogen Peroxide/metabolism , Hydrolyzable Tannins , Tetradecanoylphorbol Acetate/toxicity , 8-Hydroxy-2'-Deoxyguanosine , Caffeic Acids/pharmacology , Catechin/analogs & derivatives , Catechin/pharmacology , DNA, Neoplasm/drug effects , DNA, Neoplasm/isolation & purification , Deoxyguanosine/analogs & derivatives , Deoxyguanosine/analysis , Diterpenes/pharmacology , HeLa Cells , Humans , Oxidation-Reduction , Phenylethyl Alcohol/analogs & derivatives , Phenylethyl Alcohol/pharmacology , Tamoxifen/pharmacology , Tannins/pharmacology , Thymidine/analogs & derivatives , Thymidine/analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...